The 20 Best Vulvar Cancer Doctors in Maryland, US

Akila Viswanathan, M.D., M.P.H., is the director for the Department of Radiation Oncology and Molecular Radiation Sciences, and a professor of radiation oncology, gynecology/obstetrics and oncology for Johns Hopkins University School of Medicine. Dr. Viswanathan leads the department emphasizing excellence in clinical care, research and education. She has expertise with gynecologic cancers and their treatment, including cervical and uterine cancers and image-guided brachytherapy. She has developed numerous clinical innovations and initiated several system-wide integration efforts at all sites, including Green Spring Station, Bayview, Johns Hopkins Hospital, Suburban's Rockledge site, and Sibley Memorial Hospital for the Johns Hopkins Department of Radiation Oncology. Dr. Viswanathan earned her undergraduate degree at Harvard University, her medical degree at the University of Pittsburgh School of Medicine, followed by her Masters in Public Health and Masters in Epidemiology at the Harvard School of Public Health. She completed a residency in radiation oncology at the Joint Center for Radiation Therapy at Harvard Medical School, where she served as chief resident. She has had research grant funding through the National Cancer Institute K07, R21 and R01 programs to support efforts in gynecologic cancers, specifically looking at the identification of gynecologic tumors at the time of brachytherapy under magnetic resonance imaging. The research team has developed several novel clinical innovations. Dr. Viswanathan has been named one of America's Top Doctors by Newsweek, Who’s who in America, and a Super Doctor by the Washington Post magazine. Dr. Viswanathan served as President and Chair of the Board of the American Brachytherapy Society; Chair of Education Committee for American Society for Radiation Oncology; and, on the Gynecologic Cancer Steering Committee and the uterine cancer task force for the National Cancer Institute. Dr. Akila Viswanathan has published more than 200 articles and chapters, and lectures nationally and internationally. She is the Editor-in-Chief for Seminars in Radiation Oncology. She is on the editorial board of Gynecologic Oncology and Brachytherapy, and is an editor of several textbooks including Gynecologic Radiation Therapy: Novel Approaches to Image-Guidance and Management, Radiation Therapy Techniques for Gynecologic Cancers, and Gunderson and Tepper's Clinical Radiation Oncology. Make A Gift. Dr. Viswanathan is rated as an Elite provider by MediFind in the treatment of Vulvar Cancer. Her top areas of expertise are Vaginal Cancer, Cervical Cancer, Vulvar Cancer, Vulvectomy, and Cordotomy.

James Stuart Ferriss is an associate professor in the Johns Hopkins Department of Gynecology and Obstetrics and director of the F.J. Montz Gynecologic Oncology Fellowship Program. He is an expert in the care of women with cancers of the uterus, cervix, vulva, vagina, fallopian tubes and ovaries. Dr. Ferriss is passionate about minimally invasive approaches to surgery and has extensive experience with robotic surgery. Dr. Ferriss received his undergraduate and medical degrees from Louisiana State University. He then completed his residency in obstetrics and gynecology at the University of Texas Southwestern Medical Center and his fellowship in gynecologic oncology at the University of Virginia. Prior to joining Johns Hopkins, Dr. Ferriss was associate professor in the departments of women’s health and oncology at the University of Texas at Austin Dell Medical School. Before that, he was assistant professor in the department of obstetrics, gynecology and reproductive sciences at Temple University in Philadelphia. Dr. Ferriss’ research is focused on innovations in surgical and clinical education. Dr. Ferriss serves on a variety of boards and is a member of the Society of Gyneocologic Oncology, Mid-Atlantic Gynecologic Oncology Society, American Society of Clinical Oncology, the American College of Surgeons and the American Congress of Obstetricians and Gynecologists. He has been recognized with several awards and honors, including being named a top doctor for outstanding patient care. Dr. Ferriss’ passion for getting to know each of his patients’ values and personal treatment goals and empowering them to be active participants in their treatment defines his approach to patient care. Dr. Ferriss has special interest in supporting his patients through the entire arc of their cancer care from diagnosis to surgery, chemotherapy, and survivorship and palliative care. Videos Dr. Stuart FerrissGynecologic Oncologist Contact for Research Inquiries 600 N. Wolfe St Phipps 281 Baltimore, MD 21287 Research Summary Dr. Ferriss’ research currently focuses on increasing the diversity of patients recruited to clinical trials by understanding the factors and circumstances that prevent some patients from participating. He is also focused on innovations in surgical and clinical education. Dr. Ferriss is rated as a Distinguished provider by MediFind in the treatment of Vulvar Cancer. His top areas of expertise are Neuroendocrine Carcinoma of the Cervix, Cervical Cancer, Ovarian Cancer, Oophorectomy, and Lymphadenectomy.

Dr. Amanda Nickles Fader is a professor in the Johns Hopkins Hospital Department of Gynecology and Obstetrics and the Sidney Kimmel Cancer Center. She is the former fellowship director and division director of the Johns Hopkins Kelly Gynecologic Oncology Service and currently is Vice Chair of Gynecologic Surgical Operations and the Director of the Center for Rare Gynecologic Cancers. Additionally, she serves as the 2024-2025 President of the Society of Gynecologic Oncology. Dr. Fader received her undergraduate degree with highest distinction in music (violin performance) and pre-medicine from the University of Virginia. She earned her medical degree from the Medical College of Virginia, and completed her residency in obstetrics and gynecology at the Magee-Women’s Hospital of UPMC in Pittsburgh. Dr. Fader then underwent gynecologic oncology fellowship training at the Cleveland Clinic. She has co-authored more than 230 publications in peer-reviewed medical journals and is recognized as an expert in rare gynecologic tumors, clinical trials and quality and safety in surgery. She has a special interest in uterine serous carcinoma and low-grade serous carcinoma of the ovary and currently serves as the PI or co-PI of three international NRG Oncology clinical trials. Dr. Fader serves as a national board examiner in gynecologic oncology for the American Board of Obstetrics and Gynecology and Associate Editor of the Gynecologic Oncology journal is a member of the Rare Tumor and Uterine Corpus Committees of the NRG/Gynecologic Oncology Group. She is also co-founder of the Society of Gynecologic Oncology BRIDGES Program, a two-year longitudinal clinical trials and career development program for early-career oncologists. She has been the recipient of several research grants and awards for her research, including the Society of Gynecologic Oncology Innovations Award, the Best AAGL Paper in Minimally Invasive Gynecologic Oncology Surgery, a Department of Defense Ovarian Cancer Clinical Trials Academy Leadership Award, and National Cancer Institute Cervical SPORE grant. Dr. Fader is consistently recognized for clinical excellence on lists such as Baltimore magazine’s Top Docs and Castle Connolly’s Top Doctors, and is a recipient of the Top 10 Docs, Compassionate Doctors and Patient Choice Awards from Vitals.com. She has particular expertise with the surgical and medical management of uterine (endometrial), ovarian, cervical and vulvar cancers, as well as the treatment of women who are at high risk for developing a gynecologic malignancy. She has a special interest in caring for patients throughout the entire spectrum of their lives: from preventive oncology — minimizing key risk factors that can lead to gynecologic cancers — to survivorship initiatives addressing all aspects of recovery, including emotional well-being, sexual health and clinical follow-up. Dr. Fader is rated as a Distinguished provider by MediFind in the treatment of Vulvar Cancer. Her top areas of expertise are Ovarian Carcinosarcoma, Sertoli-Leydig Cell Tumor, Ovarian Cancer, Bladder Reconstruction, and Hernia Surgery.

Edward Tanner, M.D., is a professor of gynecologic oncology in the Johns Hopkins Medicine Department of Gynecology and Obstetrics and the medical director for women’s health in the Johns Hopkins National Capital Region. Dr. Tanner is an internationally recognized expert in gynecologic surgery and is known for his surgical skills, compassionate bedside manner, leadership and teaching abilities. Dr. Tanner’s clinical interests include surgical management of advanced gynecologic cancers, including radical debulking surgery for ovarian cancer, as well as minimally invasive surgery for early-stage female cancers. He is particularly focused on developing innovative techniques that reduce complications and speed recovery time. His research interests include sentinel lymph node mapping in endometrial and cervical cancers, exploring ways to reduce complications for patients having surgery for advanced ovarian cancer, robotic single-site surgery and identifying new treatments for patients with uterine sarcoma. He has authored more than 80 articles in peer-reviewed medical journals and has lectured nationally and internationally on sentinel lymph node techniques, uterine sarcoma and surgical innovations for gynecologic cancer. He is the chapter author of “Surgery for Endometrial Cancer” in Telinde’s Operative Gynecology, the definitive textbook for gynecologic surgery techniques in the United States. Dr. Tanner is a member of the NRG Corpus Committee, which develops clinical trials for uterine cancer on behalf of the National Cancer Institute. A Maryland native, Dr. Tanner received his medical degree from the University of Alabama at Birmingham before returning to Baltimore to complete his residency in gynecology and obstetrics at The Johns Hopkins Hospital. He completed a fellowship in gynecologic oncology at Memorial Sloan Kettering Cancer Center, where he was among the first fellows to complete an extensive training program in robotic surgery for gynecologic cancers. Dr. Tanner has served as a faculty member at The Johns Hopkins Hospital as well as the Marcia Stenn Professor and chief of gynecologic oncology at Northwestern University in Chicago. Having served as the gynecologic oncology fellowship program director at both The Johns Hopkins Hospital and Northwestern Memorial Hospital, Dr. Tanner taught the next generation of gynecologic surgeons and health care leaders. Dr. Tanner is rated as an Advanced provider by MediFind in the treatment of Vulvar Cancer. His top areas of expertise are Endometrial Stromal Sarcoma, Endometrial Cancer, Malignant Mixed Mullerian Tumor, Hernia Surgery, and Oophorectomy.

Dr. Rebecca Stone is an associate professor in the Johns Hopkins Medicine Department of Gynecology and Obstetrics. Her area of clinical expertise is gynecologic cancers, including cervical, uterine, vulvar and ovarian cancer, as well as gestational trophoblastic disease. Dr. Stone is a highly skilled surgeon with expertise in laparoscopic and robotic surgery for gynecologic tumors. She also serves as director of the Gynecology Enhanced Recovery after Surgery initiative, an innovative, multidisciplinary program that improves recovery and healing time after major abdominal surgery, as well as minimizes health care costs for patients. Dr. Stone received her undergraduate degree in biology from the University of Virginia. She earned her medical degree from the University of Virginia School of Medicine, where she subsequently completed her residency in obstetrics and gynecology. Dr. Stone performed a four-year gynecologic oncology fellowship at the University of Texas MD Anderson Cancer Center. She also earned a master’s degree in cancer biology from the University of Texas in 2010. Prior to joining Johns Hopkins, Dr. Stone was an assistant professor at the University of Arkansas for Medical Sciences, where she was one of five gynecologic oncologists serving the entire state. Dr. Stone is internationally recognized for her research pertaining to early diagnosis and treatment of ovarian cancer. She is widely published in the field of gynecologic oncology, with first-author papers in the New England Journal of Medicine and Lancet Oncology, as well as over 40 co-authored manuscripts in peer-reviewed medical journals. She was honored with an award for one of the most influential papers published in the field of obstetrics and gynecology in 2012 and with an Ovarian Cancer Research Fund Grant for “Unplugging Ovarian Cancer from the Power of Platelets.” Dr. Stone strongly believes in a multidisciplinary team approach to gynecologic cancer care. She seeks to provide women with the most advanced and personalized treatment plans while best preserving quality of life. She enjoys working with community providers so that patients are comforted by receiving care close to home. Dr. Stone is rated as an Advanced provider by MediFind in the treatment of Vulvar Cancer. Her top areas of expertise are Ovarian Carcinosarcoma, Sertoli-Leydig Cell Tumor, Ovarian Cancer, Oophorectomy, and Hernia Surgery.

Fong W. Liu, M.D., M.P.H., is an assistant professor at the Johns Hopkins University School of Medicine. Her clinical expertise includes gynecologic oncology and general gynecology and obstetrics. Dr. Liu earned her Doctor of Medicine degree from the University of Alabama. She completed her residency in obstetrics and gynecology at Beth Israel Deaconess Medical Center in Boston, Massachusetts. Dr. Liu then went on to complete her fellowship in gynecologic oncology at the University of California, Irvine. Prior to joining Johns Hopkins, Dr. Liu served as an instructor in the department of obstetrics and gynecology at Beth Israel Deaconess Medical Center. Dr. Liu is also a gynecologic oncologist at the Sandra and Malcolm Berman Cancer Institute at GBMC. Dr. Liu is rated as an Advanced provider by MediFind in the treatment of Vulvar Cancer. Her top areas of expertise are Malignant Mixed Mullerian Tumor, Endometrial Stromal Sarcoma, Endometrial Cancer, Oophorectomy, and Hernia Surgery.

Kimberly Levinson, M.D., is an associate professor in the Johns Hopkins Medicine Department of Gynecology and Obstetrics. Her areas of clinical expertise include minimally invasive surgery with both robotic and single incision laparoscopy, ovarian cancer debulking, cervical cancer and dysplasia. Dr. Levinson received her undergraduate degree from Tufts University. She earned her M.D. from the Johns Hopkins University School of Medicine and her M.P.H. from the Johns Hopkins Bloomberg School of Public Health. She completed her medical residency at the Johns Hopkins University School of Medicine and performed a clinical fellowship in gynecologic oncology at Cleveland Clinic. Dr. Levinson has also completed international research at Preventive Oncology International in Peru and the School for International Training in Chile. Dr. Levinson joined the Johns Hopkins faculty in 2014. Her research interests include health care disparities in gynecologic tumors, cervical cancer prevention and treatment, and surgical innovation. She has published numerous manuscripts in gynecologic oncology involving these and other various research topics. Dr. Levinson is currently a principal investigator in the Specialized Program of Research Excellence (SPORE) in Cervical Cancer. In addition, she has a strong commitment to education, and she is the assistant director of the Johns Hopkins residency program and the associate director of the Gynecologic Oncology fellowship. Dr. Levinson is a member of the American College of Obstetricians and Gynecologists, the Society of Gynecologic Oncology, and the American Medical Association. Dr. Levinson was recognized with a Robert B. Hunt Award for Best Paper Published in the Journal of Minimally Invasive Gynecology in 2014. Dr. Levinson is rated as an Advanced provider by MediFind in the treatment of Vulvar Cancer. Her top areas of expertise are Endometrial Cancer, Testicular Yolk Sac Tumor, Ovarian Cancer, Hysterectomy, and Lymphadenectomy.

Colleen McCormick, M.D., M.P.H., is an assistant professor in the Department of Gynecology and Obstetrics at the Johns Hopkins University School of Medicine in Baltimore. Her areas of clinical expertise include gynecologic oncology with a focus on cervical and endometrial cancers, complex cancer cases and surgery for gynecologic cancers. A Baltimore native, Dr. McCormick received her undergraduate degree from Earlham College in Richmond, Virginia. Her advanced degrees include a doctorate in medicine and a Master of Public Health from Johns Hopkins. Dr. McCormick completed her residency as well as the F.J. Montz Fellowship in Gynecologic Oncology at The Johns Hopkins Hospital. She has significant clinical experience, initially in Portland, Oregon, where she was the medical director at Legacy Gynecologic Oncology. She was most recently at the University of New Mexico before returning home to Johns Hopkins and Baltimore. Her research interests include clinical trial programs, focusing on increasing diversity and inclusion in clinical trials. Deeply invested in patient experience, she recently served as a patient safety officer at the University of New Mexico, and she has researched practitioner and patient perspectives regarding endometrial cancer care. She has additional training in palliative care and genetic counseling, and she strongly values being able to accompany patients through their entire cancer journey. Dr. McCormick is a published author and has been invited to lecture both regionally and nationally. Dr. Mccormick is rated as an Advanced provider by MediFind in the treatment of Vulvar Cancer. Her top areas of expertise are Ovarian Cancer, Malignant Mixed Mullerian Tumor, Endometrial Cancer, Ovarian Carcinosarcoma, and Bladder Reconstruction.

Teresa Diaz is an Obstetrics and Gynecologist in Baltimore, Maryland. Dr. Diaz is rated as a Distinguished provider by MediFind in the treatment of Vulvar Cancer. Her top areas of expertise are Endometrial Cancer, Endometrial Stromal Sarcoma, Vulvar Cancer, Ureteroscopy, and Hysterectomy.

Hyung Ryu is an Obstetrics and Gynecologist in Baltimore, Maryland. Dr. Ryu is rated as a Distinguished provider by MediFind in the treatment of Vulvar Cancer. His top areas of expertise are Cervical Cancer, Neuroendocrine Carcinoma of the Cervix, Endometrial Cancer, Malignant Mixed Mullerian Tumor, and Hernia Surgery.

Abbie Fields is an Oncologist in Easton, Maryland. Dr. Fields is rated as a Distinguished provider by MediFind in the treatment of Vulvar Cancer. Her top areas of expertise are Endometrial Cancer, Vulvar Cancer, Sertoli-Leydig Cell Tumor, Bladder Reconstruction, and Hysterectomy.

Dwight Im is an Oncologist in Baltimore, Maryland. Dr. Im is rated as a Distinguished provider by MediFind in the treatment of Vulvar Cancer. His top areas of expertise are Rectocele, Endometrial Cancer, Endometrial Stromal Sarcoma, Hysterectomy, and Oophorectomy.

Fouad Abbas is an Obstetrics and Gynecologist in Baltimore, Maryland. Dr. Abbas is rated as a Distinguished provider by MediFind in the treatment of Vulvar Cancer. His top areas of expertise are Endometrial Cancer, Malignant Mixed Mullerian Tumor, Sertoli-Leydig Cell Tumor, Oophorectomy, and Ureteroscopy.

Dr. Cornelia Trimble is a professor in the Department of Gynecology and Obstetrics. She has joint appointments in the Departments of Gynecology and Obstetrics, Oncology, and Pathology. Dr. Trimble completed her residency in anatomic pathology at Cornell University Medical Center, followed by a fellowship in gynecologic pathology and a residency in gynecology and obstetrics at The Johns Hopkins Hospital. Her clinical interest and expertise is in developing new ways to intercept cancers — treating pre-invasive, cancer precursor lesions — caused by HPV. Her work has focused on two nonsurgical strategies: (1) immunotherapy via therapeutic HPV vaccination, and (2) repurposing artesunate, a plant-derived compound used to treat malaria, as a topical treatment administered by the patient herself to treat high-grade, intraepithelial HPV lesions. Her work has shown proof-of-principle, that it is indeed possible to eliminate HPV pre-cancers without surgery, and has been recognized internationally. Dr. Trimble has dedicated herself to delivering cutting-edge care to girls and women who have a very common problem, caused by a very common virus, HPV. She values respect, integrity, quality and compassion in caring for her patients. Dr. Trimble is rated as an Experienced provider by MediFind in the treatment of Vulvar Cancer. Her top areas of expertise are Cervical Dysplasia, Human Papillomavirus Infection, Vulvar Cancer, and Cervical Cancer.

Mark Goldstein is a Hematologist Oncology provider in Bethesda, Maryland. Dr. Goldstein is rated as an Experienced provider by MediFind in the treatment of Vulvar Cancer. His top areas of expertise are Childhood Iron Deficiency Anemia, Anal Cancer, Myelodysplastic Syndrome (MDS), and Pleuropulmonary Blastoma.

Dr. Lipson is an internationally-recognized skin cancer and immunotherapy specialist at Johns Hopkins. He received his medical degree in 2005 from the Mount Sinai School of Medicine in New York City, where he graduated with distinction in research. He completed his internship and residency in Internal Medicine at The Johns Hopkins Hospital, and completed a Medical Oncology fellowship at the Johns Hopkins Kimmel Cancer Center. Dr. Lipson leads cutting edge clinical trials for patients with melanoma and other skin cancers. As a member of the Johns Hopkins Melanoma and Cancer Immunology Programs, he focuses on evaluating novel therapies for patients with high-risk or advanced disease. Dr. Lipson’s publications include the first reports of organ transplant recipients treated with immune checkpoint inhibitors for advanced cancer, and the first description of kidney retransplantation performed after immunotherapy–related organ rejection. Based on his published work, Dr. Lipson initiated a clinical trial testing a novel combination of immune-based therapies for kidney transplant recipients with advanced selected cancers. Results from this trial - the first of its kind - were reported in 2022 at an international oncology meeting. Dr. Lipson is a leader in the clinical development of relatlimab, an antibody blocking the LAG-3 immune checkpoint. He leads a phase 2 trial testing combination immune checkpoint inhibitor therapy—including anti-LAG-3—for patients with advanced basal cell carcinoma. In June 2021, Dr. Lipson presented findings from the first phase 3 study establishing the LAG-3 pathway as the third immune checkpoint pathway in history, after CTLA-4 and PD-1, for which blockade has clinical benefit. This trial supported the FDA's approval of a new therapy for patients with advanced melanoma. In addition to his research activities, Dr. Lipson is an educator in the field of cancer immunotherapy. Many of his lectures focus on the management of immune-mediated drug toxicities associated with novel cancer drugs. Dr. Lipson conducts regular clinical practices in Baltimore, Maryland and at Sibley Memorial Hospital in Washington, D.C. as part of the multidisciplinary Melanoma Program at Johns Hopkins. Dr. Lipson is rated as an Experienced provider by MediFind in the treatment of Vulvar Cancer. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Metastatic Uveal Melanoma, Squamous Cell Skin Carcinoma, and Pancreaticoduodenectomy.

Dr. William H. Sharfman is an associate professor of oncology and dermatology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include cutaneous oncology, dermatology and immunotherapy. He helped create the well-established Melanoma Program at the Johns Hopkins Kimmel Cancer Center in 1994. Dr. Sharfman serves as the director of cutaneous oncology and clinical co-director for oncology at the Johns Hopkins Melanoma Program. He earned his M.D. from the University of Toledo College of Medicine. He completed his residency at Cleveland Clinic and performed a fellowship in hematology and oncology at Cleveland Clinic. Dr. Sharfman's research interests include novel therapies for high risk and advanced melanoma patients. Dr. Sharfman is rated as an Experienced provider by MediFind in the treatment of Vulvar Cancer. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Eccrine Porocarcinoma, and Pancreatic Cancer.

Learn more at marylandoncology.com. Dr. Sastry is rated as an Experienced provider by MediFind in the treatment of Vulvar Cancer. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Iron Deficiency Anemia, and Childhood Iron Deficiency Anemia.

Brian Wildey, M.D., is a gynecologist and obstetrician practicing in Baltimore and Odenton, Maryland. He provides a full spectrum of general gynecology and obstetrics care for patients of all ages, whether their needs be contraception, obstetrical care, minimally invasive surgery or health maintenance. Dr. Wildey is an assistant professor in the Johns Hopkins University School of Medicine’s Department of Gynecology and Obstetrics. He attended medical school at the University of New Mexico and began a residency in gynecology and obstetrics at the Tulane University School of Medicine in New Orleans. He completed a residency at the University of Texas Houston McGovern Medical School after Hurricane Katrina devastated New Orleans in 2005. Before joining the Johns Hopkins medical school faculty, Dr. Wildey practiced in Grand Forks, North Dakota, for over 13 years, serving the people of North Dakota, western Minnesota, the Grand Forks Air Force Base and the Spirit Lake Tribe area. He also was an assistant professor in the obstetrics and gynecology department at the University of North Dakota School of Medicine and Health Sciences. An avid learner, Dr. Wildey finds joy and fulfillment learning from his patients and students each and every day. Selected Publications Angela L. Lang, Lindsay C. Turner, Kristen M. Voegtline, Sarah B. Olson, Brian Wildey, Victoria L. Handa. Impact of COVID-19 on Gynecological and Obstetric Services at Two Large Health Systems. 2021. (MS Submitted) Abdeelrahman AlAshqar, Brian Wildey, Golsa Yazdy, Metin E. Goktepe, Gokhan S. Kilic, Mostafa A. Borahay. 2021. Predictors of same-day discharge after minimally invasive hysterectomy for benign indication. IJGO 2021 IJD-D-21-01123R1. Dr. Wildey is rated as an Experienced provider by MediFind in the treatment of Vulvar Cancer. His top areas of expertise are Vulvar Cancer, Vaginal Bleeding Between Periods, Solitary Fibrous Tumor, and Carney Complex.

Stéphanie Gaillard is a medical oncologist who specializes in the treatment of gynecologic malignancies. She recently joined the faculty of the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and is their Director of Gynecologic Cancer Trials. Dr. Gaillard earned her medical degree and doctoral degree in cancer biology from Duke University. Following medical school, she underwent residency training in Internal Medicine and fellowship training in Medical Oncology at the Johns Hopkins School of Medicine. Dr. Gaillard’s research focuses on the development of clinical trials aimed at improving outcomes by incorporating promising new biologic, targeted, and immune therapies into standard treatment regimens. Her translational research program focuses on understanding the immune environment associated with gynecologic cancers and mechanisms of resistance to current therapies. Dr. Gaillard is rated as an Experienced provider by MediFind in the treatment of Vulvar Cancer. Her top areas of expertise are Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Tissue Biopsy, and Salpingo-Oophorectomy.